Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Paradigm Biopharmaceuticals Ltd. ( (AU:PAR) ) just unveiled an update.
Paradigm Biopharmaceuticals Ltd. has announced a proposed bonus issue of securities, which includes a significant number of Loyalty and Piggyback Options. This move, scheduled for completion in early February 2025, represents a strategic effort to enhance shareholder value and potentially strengthen the company’s market position by rewarding existing investors and encouraging long-term investment.
More about Paradigm Biopharmaceuticals Ltd.
YTD Price Performance: 22.96%
Average Trading Volume: 3,620
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $134.3M
See more data about PAR stock on TipRanks’ Stock Analysis page.